Astera Labs (NASDAQ:ALAB) Trading Down 6.9% – Should You Sell?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) were down 6.9% on Tuesday . The stock traded as low as $286.97 and last traded at $288.85. 5,694,255 shares changed hands during trading, an increase of 7% from the average daily volume of 5,309,042 shares. The stock had previously closed at $310.40.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Stifel Nicolaus boosted their price target on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Barclays lifted their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Morgan Stanley upped their price target on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Citigroup restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $348.33.

Astera Labs Trading Down 5.3%

The company has a market capitalization of $49.36 billion, a price-to-earnings ratio of 140.86 and a beta of 3.77. The stock’s fifty day simple moving average is $321.34 and its 200-day simple moving average is $258.86.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the previous year, the firm posted $0.44 earnings per share. The company’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity

In other news, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 592,244 shares of company stock worth $209,729,973 over the last three months. Company insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in ALAB. Keating Financial Advisory Services Inc. acquired a new position in Astera Labs during the 2nd quarter worth approximately $25,000. Archer Investment Corp acquired a new stake in shares of Astera Labs in the 2nd quarter valued at $30,000. Transamerica Financial Advisors LLC purchased a new stake in shares of Astera Labs during the 2nd quarter worth $35,000. Continuum Advisory LLC purchased a new stake in shares of Astera Labs during the 2nd quarter worth $37,000. Finally, Johnson Financial Group Inc. acquired a new position in shares of Astera Labs during the second quarter worth $43,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.